India Pesticides Ltd
India Pesticides Limited is one of the globally operating agro-chemical manufactures in India, since 1984. The company is the sole Indian manufacturer and among the top five manufacturers globally for several Technicals, such as Folpet, Thiocarbamate Herbicide, and several other products [1]
- Market Cap ₹ 2,079 Cr.
- Current Price ₹ 181
- High / Low ₹ 432 / 174
- Stock P/E 28.9
- Book Value ₹ 75.2
- Dividend Yield 0.42 %
- ROCE 10.7 %
- ROE 7.62 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Part of BSE Allcap BSE Commodities Nifty Total Market Nifty Microcap 250 BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|
223 | 248 | 341 | 480 | 649 | 716 | 885 | 681 | 726 | |
163 | 193 | 275 | 386 | 466 | 502 | 687 | 594 | 627 | |
Operating Profit | 60 | 55 | 65 | 94 | 183 | 214 | 198 | 87 | 99 |
OPM % | 27% | 22% | 19% | 20% | 28% | 30% | 22% | 13% | 14% |
2 | 3 | 5 | 10 | 6 | 13 | 13 | 15 | 17 | |
Interest | 6 | 4 | 6 | 5 | 3 | 7 | 6 | 4 | 4 |
Depreciation | 3 | 4 | 4 | 5 | 6 | 8 | 11 | 15 | 16 |
Profit before tax | 53 | 50 | 61 | 93 | 180 | 212 | 193 | 84 | 97 |
Tax % | 33% | 35% | 28% | 24% | 25% | 25% | 25% | 27% | |
35 | 33 | 44 | 71 | 135 | 158 | 144 | 61 | 72 | |
EPS in Rs | 1,113.42 | 1,030.79 | 1,379.83 | 2,224.32 | 12.04 | 13.75 | 12.54 | 5.31 | 6.25 |
Dividend Payout % | 2% | 2% | 1% | 1% | 3% | 5% | 6% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 2% |
TTM: | -11% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | -23% |
TTM: | -29% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -16% |
1 Year: | -37% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 18% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 11 | 12 | 12 | 12 | 12 |
Reserves | 107 | 141 | 184 | 254 | 378 | 627 | 763 | 816 | 854 |
43 | 46 | 61 | 28 | 30 | 15 | 6 | 20 | 25 | |
42 | 51 | 69 | 81 | 97 | 131 | 135 | 148 | 228 | |
Total Liabilities | 195 | 240 | 317 | 366 | 517 | 784 | 915 | 996 | 1,119 |
61 | 69 | 70 | 99 | 124 | 163 | 237 | 267 | 308 | |
CWIP | 3 | 3 | 5 | 1 | 12 | 44 | 27 | 41 | 21 |
Investments | 2 | 3 | 3 | 3 | 10 | 20 | 17 | 41 | 43 |
130 | 165 | 239 | 262 | 371 | 557 | 635 | 647 | 748 | |
Total Assets | 195 | 240 | 317 | 366 | 517 | 784 | 915 | 996 | 1,119 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
38 | 16 | -3 | 75 | 83 | 77 | 46 | 120 | |
-6 | -13 | -7 | -31 | -84 | -133 | -23 | -125 | |
-32 | -2 | 9 | -39 | -4 | 71 | -29 | 2 | |
Net Cash Flow | 0 | 1 | -1 | 5 | -5 | 14 | -6 | -3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 143 | 184 | 191 | 139 | 120 | 126 | 108 | 128 |
Inventory Days | 56 | 75 | 60 | 88 | 163 | 175 | 201 | |
Days Payable | 108 | 116 | 95 | 92 | 110 | 74 | 90 | |
Cash Conversion Cycle | 143 | 132 | 150 | 104 | 116 | 179 | 209 | 240 |
Working Capital Days | 140 | 158 | 175 | 130 | 132 | 164 | 165 | 193 |
ROCE % | 32% | 30% | 37% | 52% | 41% | 28% | 11% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12 Nov - Transcript of the Earnings call for the quarter & half-year ended 30th September, 2024.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
8 Nov - Audio recording of Q2 FY2025 earnings conference call.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
7 Nov - Investor Presentation in relation to Financial Results for the quarter & half year ended September 30, 2024.
-
Intimation Regarding Approval Of The Technical Material Product
7 Nov - Approval of Technical Material Product for export.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Nov - Newspaper Publication for the quarter and half year ended 30th September, 2024
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023TranscriptPPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Jul 2021Transcript PPT
Leading pesticides company [1]
An R&D-driven chemical manufacturer of agrochem technical, APIs, and formulation business.